Adma Biologics (ADMA) Tax Provisions (2011 - 2025)
Adma Biologics (ADMA) posted Tax Provisions of $12.2 million for Q4 2025, up 10.18% on a QoQ basis from $11.1 million in Q3 2025, and up 180.61% year-over-year from $4.4 million in Q4 2024.
Adma Biologics (ADMA) Tax Provisions (2011 - 2025) Analysis & Trends
Adma Biologics' Tax Provisions history runs 4 years deep, the most recent figure standing at $12.2 million for Q4 2025.
- Quarterly Tax Provisions rose 180.61% year-over-year to $12.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $35.7 million (up 459.75% YoY) and the FY2025 annual result came in at $35.7 million, up 459.74% from the prior year.
- Tax Provisions was $12.2 million for Q4 2025 at Adma Biologics, up from $11.1 million in the prior quarter.
- Across five years, Tax Provisions topped out at $12.2 million in Q4 2025 and bottomed at -$15.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | 12.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.22 Mn |
| Sep 30, 2025 | 11.09 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 6.55 Mn |
| Dec 31, 2024 | -15.16 Mn |
| Sep 30, 2024 | 840,000.00 |
| Jun 30, 2024 | 3.79 Mn |
| Mar 31, 2024 | 595,000.00 |
| Mar 31, 2012 | -617,615.00 |
| Mar 31, 2011 | -320,765.00 |